Back |
home / stock / jspr / jspr message board
Subject | By | Source | When |
---|---|---|---|
Does not look good | Docstemcell2020 | investorshub | 01/14/2022 7:26:36 PM |
znewcar1: JSPR 17% v1,3M c9.99 f37,8M H10.69 | znewcar1 | investorshangout | 12/10/2021 2:51:08 AM |
S-1 filing has warrant info: | pcjockey | investorshub | 12/09/2021 1:21:20 AM |
Anyone here have any of the warrants--could not | theswordman | investorshub | 11/15/2021 7:07:23 AM |
#$JSPR back to $14 plus very soon, credit | ZipCash | investorshub | 11/10/2021 4:32:30 PM |
Bounce back north is imminent ! Scooping | ZipCash | investorshub | 10/27/2021 11:04:40 PM |
Absolutely! Its gonna pop soon | ipo_dude | investorshub | 10/21/2021 6:33:17 AM |
With a low float like this and forward | DOA | investorshub | 10/19/2021 7:04:53 PM |
Now a bagholder lol. They pumped it and | Roadtojourney | investorshub | 10/18/2021 8:09:06 PM |
znewcar1: JSPR 31% v35,7M c16.42 f36,5M H18.88 | znewcar1 | investorshangout | 10/18/2021 2:39:31 AM |
Break of $20 this monday imo. | ZipCash | investorshub | 10/16/2021 9:08:15 PM |
18.55 | crudeoil24 | investorshub | 10/15/2021 7:29:35 PM |
Theres fireworks going on and so much quiet | Roadtojourney | investorshub | 10/15/2021 7:23:27 PM |
znewcar1: morning gap up and fade now has vol >$17 | znewcar1 | investorshangout | 10/15/2021 7:21:25 PM |
Weeee | Roadtojourney | investorshub | 10/15/2021 7:12:46 PM |
Yup! | crudeoil24 | investorshub | 10/15/2021 1:23:56 PM |
WOW $JSPR BEAST double top was around | TheFinalCD | investorshub | 10/15/2021 1:23:30 PM |
BOOOOOOOMMMM!!!! | crudeoil24 | investorshub | 10/15/2021 1:23:29 PM |
znewcar1: JSPR 105% v91,7M c14.79 f36,5M H18.24 | znewcar1 | investorshangout | 10/13/2021 8:05:29 PM |
News, Short Squeeze, Breakout and More Instantly...
Jasper Therapeutics Inc. Company Name:
JSPR Stock Symbol:
NASDAQ Market:
Jasper Therapeutics Inc. Website:
REDWOOD CITY, Calif., June 19, 2024 (GLOBE NEWSWIRE) -- Jasper Therapeutics, Inc. (Nasdaq: JSPR) (Jasper), a clinical stage biotechnology company focused on development of briquilimab, a novel antibody therapy targeting c-Kit (CD117) to address mast cell driven diseases such as chronic spontaneou...
REDWOOD CITY, Calif., June 17, 2024 (GLOBE NEWSWIRE) -- Jasper Therapeutics, Inc. (Nasdaq: JSPR) (Jasper), a biotechnology company focused on development of briquilimab, a novel antibody therapy targeting c-Kit (CD117) to address mast cell driven diseases such as chronic spontaneous urticaria (CS...
2024-06-16 16:36:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...